CNS Pharmaceuticals Inc (CNSP)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current CNSP market cap is 248.89k. The company's latest EPS is USD -79.5270 and P/E is -0.01.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4.93M | -4.03M | -4.53M | -5.38M | -3.55M |
| Net Income | -4.93M | -4.02M | -4.52M | -5.38M | -3.55M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.83M | -9.46M | -14.03M | -15.27M | -18.87M |
| Net Income | -3.88M | -9.46M | -14.04M | -15.27M | -18.85M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.42M | 6.45M | 2.33M | 1.7M | 1.66M |
| Total Liabilities | 3.92M | 4M | 4.07M | 6.13M | 6.09M |
| Total Equity | 3.49M | 2.45M | -1.74M | -4.43M | -4.43M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.91M | 15.85M | 8.76M | 13.05M | 1.7M |
| Total Liabilities | 311k | 1.91M | 2.14M | 4.92M | 6.13M |
| Total Equity | 7.6M | 13.95M | 6.62M | 8.13M | -4.43M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.83M | -8.23M | -11.6M | -14.14M | -3.19M |
| Investing | N/A | N/A | -2k | -4k | N/A |
| Financing | -119k | 2.45M | 2.46M | 4.64M | 3.46M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.55M | -7.32M | -13.54M | -10.56M | -14.14M |
| Investing | -20k | -18k | -6k | -4k | -4k |
| Financing | 10.26M | 14.13M | 4.51M | 15.61M | 4.64M |
| Market Cap | 248.89k |
| Price to Earnings Ratio | -0.01 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.46 |
| Price to Book Ratio | -0.06 |
| Dividend Yield | - |
| Shares Outstanding | 237.04k |
| Average Volume (1 week) | 358.06k |
| Average Volume (1 Month) | 4.66M |
| 52 Week Change | -99.98% |
| 52 Week High | 6,875.00 |
| 52 Week Low | 1.00 |
| Spread (Intraday) | 0.03 (2.78%) |
| Company Name | CNS Pharmaceuticals Inc |
| Address |
112 north curry street carson city, nevada 89703 |
| Website | https://www.cnspharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
